<info type="GeneOrGeneProduct">Phosphatidylinositol 4-kinase IIb</info> negatively regulates <info type="DiseaseOrPhenotypicFeature">invadopodia formation</info> and suppresses an invasive cellular <info type="DiseaseOrPhenotypicFeature">phenotype</info>.

The type II <info type="GeneOrGeneProduct">phosphatidylinositol 4-kinase</info> (<info type="GeneOrGeneProduct">PI4KII</info>) enzymes synthesize the lipid <info type="ChemicalEntity">phosphatidylinositol 4-phosphate</info> (<info type="ChemicalEntity">PI(4)P</info>), which has been detected at the <info type="CellLine">Golgi complex</info> and <info type="CellLine">endosomal compartments</info> and recruits <info type="GeneOrGeneProduct">clathrin</info> adaptors. Despite common mechanistic similarities between the isoforms, the extent of their redundancy is unclear. We found that depletion of <info type="GeneOrGeneProduct">PI4KIIa</info> and <info type="GeneOrGeneProduct">PI4KIIb</info> using <info type="ChemicalEntity">small interfering RNA</info> led to <info type="GeneOrGeneProduct">actin</info> remodeling. Depletion of <info type="GeneOrGeneProduct">PI4KIIb</info> also induced the formation of <info type="DiseaseOrPhenotypicFeature">invadopodia</info> containing <info type="GeneOrGeneProduct">membrane type I matrix metalloproteinase</info> (<info type="GeneOrGeneProduct">MT1-MMP</info>). Depletion of <info type="GeneOrGeneProduct">PI4KII</info> isoforms also differentially affected <info type="CellLine">trans-Golgi network</info> (<info type="GeneOrGeneProduct">TGN</info>) pools of <info type="ChemicalEntity">PI(4)P</info> and post-TGN traffic. <info type="GeneOrGeneProduct">PI4KIIb</info> depletion caused increased <info type="GeneOrGeneProduct">MT1-MMP</info> trafficking to invasive structures at the <info type="CellLine">plasma membrane</info> and was accompanied by reduced colocalization of <info type="GeneOrGeneProduct">MT1-MMP</info> with membranes containing the endosomal markers <info type="GeneOrGeneProduct">Rab5</info> and <info type="GeneOrGeneProduct">Rab7</info> but increased localization with the exocytic <info type="GeneOrGeneProduct">Rab8</info>. Depletion of <info type="GeneOrGeneProduct">PI4KIIb</info> was sufficient to confer an aggressive invasive <info type="DiseaseOrPhenotypicFeature">phenotype</info> on minimally invasive <info type="CellLine">HeLa</info> and <info type="CellLine">MCF-7</info> <info type="CellLine">cell lines</info>. Mining oncogenomic databases revealed that loss of the <info type="GeneOrGeneProduct">PI4K2B</info> allele and underexpression of <info type="GeneOrGeneProduct">PI4KIIb</info> <info type="GeneOrGeneProduct">mRNA</info> are associated with <info type="DiseaseOrPhenotypicFeature">human cancers</info>. This finding supports the cell data and suggests that <info type="GeneOrGeneProduct">PI4KIIb</info> may be a clinically significant suppressor of invasion. We propose that <info type="GeneOrGeneProduct">PI4KIIb</info> synthesizes a pool of <info type="ChemicalEntity">PI(4)P</info> that maintains <info type="GeneOrGeneProduct">MT1-MMP</info> traffic in the degradative pathway and suppresses the formation of <info type="DiseaseOrPhenotypicFeature">invadopodia</info>.